Tolvaptan — Dosing in CKD & Dialysis

Tolvaptan (Vasopressin Antagonist): renal dosing adjustments, dialyzability (Dialysis may not be effective (protein binding above 98%, per the labels)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrology professionals.

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.